Clinical Trials for Mesothelioma Patients: Cisplatin, Imatinib Mesylate, and Pemetrexed Outcomes Measures
Read about the outcomes measures for a current clinical trial being conducted to study the effects of Cisplatin, Imatinib Mesylate, and Pemetrexed or patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Lille, France.
Primary Outcome Measures:
• Determine the maximum tolerated dose of the combination of cisplatin, imatinib mesylate, and pemetrexed. [ Time Frame: 2 Years ] [ Designated as safety issue: No ] Secondary Outcome Measures:
• Explore the biologic effects of cisplatin, imatinib mesylate, and pemetrexed on tumor tissue by histologic analysis of biopsy tissue. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
• Explore the biologic effects of cisplatin, imatinib mesylate, and pemetrexed on tumor tissue by non-invasive assessments of tumor vascularity. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
• Explore the biologic effects of cisplatin, imatinib mesylate, and pemetrexed on tumor tissue by electron microscopy analysis of endothelial cell architecture. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
• Explore the effects of cisplatin, imatinib mesylate, and pemetrexed on surrogate markers in serum. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
• Assess the rate of response to therapy. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
• Determine the doses of the combination regimen of cisplatin, imatinib mesylate, and pemetrexed that enables de-phosphorylation of PDGF-R on malignant mesothelioma tumor cells. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
• Determine the pharmacokinetic interaction between agents in this combination regimen. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health
Other helpful links:
Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney



Clinical drug study of pemetrexed disodium on mesothelioma patients